Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience.

导出 OA

翻译打印收藏纠错

作者： Ilona,Kronig ^[1] ; Stavroula,Masouridi-Levrat ^[2] ; Yves,Chalandon ^[2] ; Emmanouil,Glampedakis ^[3] ; Nathalie,Vernaz ^[4] ; Christian,Van Delden ^[1] ; Dionysios,Neofytos ^[5]

作者单位： Division of Infectious Diseases, University Hospital of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211, Geneva, Switzerland. ^[1] Bone Marrow Transplant Unit, Division of Hematology, Faculty of Medicine, University Hospital of Geneva, University of Geneva, Geneva, Switzerland. ^[2] Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland. ^[3] Geneva University Hospitals, University of Geneva, Geneva, Switzerland. ^[4] Division of Infectious Diseases, University Hospital of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211, Geneva, Switzerland. dionysios.neofytos@hcuge.ch. ^[5]

关键词 Acute myelogenous leukemia Allogeneic hematopoietic cell transplant recipients Invasive mold infections Isavuconazole Prophylaxis Treatment

主题词抗真菌药(Antifungal Agents);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);腈类(Nitriles);吡啶类(Pyridines);回顾性研究(Retrospective Studies);三唑类(Triazoles)

DOI 10.1007/s11046-021-00583-9

PMID 34432216

发布时间 2022-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交